Autopsy report · NCT00266214
Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome
Cause of deathFunding or business
“Sponsor decision”
Life of this trial
- Registered 1 month after it had already started.
- Ran for about 1 year 2 months before it stopped.
- 210 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Sponsor type
- Industry
- Conditions
- Carpal Tunnel Syndrome
- Interventions
- lidocaine patch 5%
- Participants
- 210
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.